Immuno-Oncology Market in UK - Industry Outlook and Forecast 2020-2026
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
This report contains market size and forecasts of Immuno-Oncology in UK, including the following market information:
UK Immuno-Oncology Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in UK Immuno-Oncology Market 2019 (%)
The global Immuno-Oncology market was valued at 33390 million in 2019 and is projected to reach US$ 56950 million by 2026, at a CAGR of 14.3% during the forecast period. While the Immuno-Oncology market size in UK was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
COVID-19 pandemic has big impact on Immuno-Oncology businesses, with lots of challenges and uncertainty faced by many players of Immuno-Oncology in UK. This report also analyses and evaluates the COVID-19 impact on Immuno-Oncology market size in 2020 and the next few years in UK
Total Market by Segment:
UK Immuno-Oncology Market, By Type, 2015-2020, 2021-2026 ($ millions)
UK Immuno-Oncology Market Segment Percentages, By Type, 2019 (%)
UK Immuno-Oncology Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Immuno-Oncology Market Competitors Revenues in UK, by Players 2015-2020 (Estimated), ($ millions)
Total Immuno-Oncology Market Competitors Revenues Share in UK, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
This report contains market size and forecasts of Immuno-Oncology in UK, including the following market information:
UK Immuno-Oncology Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in UK Immuno-Oncology Market 2019 (%)
The global Immuno-Oncology market was valued at 33390 million in 2019 and is projected to reach US$ 56950 million by 2026, at a CAGR of 14.3% during the forecast period. While the Immuno-Oncology market size in UK was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
COVID-19 pandemic has big impact on Immuno-Oncology businesses, with lots of challenges and uncertainty faced by many players of Immuno-Oncology in UK. This report also analyses and evaluates the COVID-19 impact on Immuno-Oncology market size in 2020 and the next few years in UK
Total Market by Segment:
UK Immuno-Oncology Market, By Type, 2015-2020, 2021-2026 ($ millions)
UK Immuno-Oncology Market Segment Percentages, By Type, 2019 (%)
- Immune Checkpoint Inhibitors
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
- Others
UK Immuno-Oncology Market Segment Percentages, By Application, 2019 (%)
- Hospitals
- Drugstores
- Others
The report also provides analysis of leading market participants including:
Total Immuno-Oncology Market Competitors Revenues in UK, by Players 2015-2020 (Estimated), ($ millions)
Total Immuno-Oncology Market Competitors Revenues Share in UK, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Bristol-Myers Squibb
- Merck & Co., Inc.
- Roche AG
- AstraZeneca, Plc
- Sanofi S.A.
- Dendreon Pharmaceuticals
- Novartis
- Gilead Sciences Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Immuno-Oncology Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: UK Immuno-Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 UK IMMUNO-ONCOLOGY OVERALL MARKET SIZE
2.1 UK Immuno-Oncology Market Size: 2020 VS 2026
2.2 UK Immuno-Oncology Revenue, Prospects & Forecasts: 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Immuno-Oncology Players in UK (including Foreign and Local Companies)
3.2 Top UK Immuno-Oncology Companies Ranked by Revenue
3.3 UK Immuno-Oncology Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Immuno-Oncology Companies in UK, by Revenue in 2019
3.5 UK Manufacturers Immuno-Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-Oncology Players in UK
3.6.1 List of UK Tier 1 Immuno-Oncology Companies
3.6.2 List of UK Tier 2 and Tier 3 Immuno-Oncology Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - UK Immuno-Oncology Market Size Markets, 2020 & 2026
4.1.2 Immune Checkpoint Inhibitors
4.1.3 Cytokine-Based Immunotherapy
4.1.4 Cancer Vaccines
4.1.5 CAR-T Cell Therapy
4.1.6 Others
4.2 By Type - UK Immuno-Oncology Revenue & Forecasts
4.2.1 By Type - UK Immuno-Oncology Revenue, 2015-2020
4.2.2 By Type - UK Immuno-Oncology Revenue, 2021-2026
4.2.3 By Type - UK Immuno-Oncology Revenue Market Share, 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - UK Immuno-Oncology Market Size, 2020 & 2026
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - UK Immuno-Oncology Revenue & Forecasts
5.2.1 By Application - UK Immuno-Oncology Revenue, 2015-2020
5.2.2 By Application - UK Immuno-Oncology Revenue, 2021-2026
5.2.3 By Application - UK Immuno-Oncology Revenue Market Share, 2015-2026
6 PLAYERS PROFILES
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporate Summary
6.1.2 Bristol-Myers Squibb Business Overview
6.1.3 Bristol-Myers Squibb Immuno-Oncology Major Product Offerings
6.1.4 Bristol-Myers Squibb Revenue in UK (2015-2020)
6.1.5 Bristol-Myers Squibb Key News
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Corporate Summary
6.2.2 Merck & Co., Inc. Business Overview
6.2.3 Merck & Co., Inc. Immuno-Oncology Major Product Offerings
6.2.4 Merck & Co., Inc. Revenue in UK (2015-2020)
6.2.5 Merck & Co., Inc. Key News
6.3 Roche AG
6.3.1 Roche AG Corporate Summary
6.3.2 Roche AG Business Overview
6.3.3 Roche AG Immuno-Oncology Major Product Offerings
6.3.4 Roche AG Revenue in UK (2015-2020)
6.3.5 Roche AG Key News
6.4 AstraZeneca, Plc
6.4.1 AstraZeneca, Plc Corporate Summary
6.4.2 AstraZeneca, Plc Business Overview
6.4.3 AstraZeneca, Plc Immuno-Oncology Major Product Offerings
6.4.4 AstraZeneca, Plc Revenue in UK (2015-2020)
6.4.5 AstraZeneca, Plc Key News
6.5 Sanofi S.A.
6.5.1 Sanofi S.A. Corporate Summary
6.5.2 Sanofi S.A. Business Overview
6.5.3 Sanofi S.A. Immuno-Oncology Major Product Offerings
6.5.4 Sanofi S.A. Revenue in UK (2015-2020)
6.5.5 Sanofi S.A. Key News
6.6 Dendreon Pharmaceuticals
6.6.1 Dendreon Pharmaceuticals Corporate Summary
6.6.2 Dendreon Pharmaceuticals Business Overview
6.6.3 Dendreon Pharmaceuticals Immuno-Oncology Major Product Offerings
6.6.4 Dendreon Pharmaceuticals Revenue in UK (2015-2020)
6.6.5 Dendreon Pharmaceuticals Key News
6.7 Novartis
6.6.1 Novartis Corporate Summary
6.6.2 Novartis Business Overview
6.6.3 Novartis Immuno-Oncology Major Product Offerings
6.4.4 Novartis Revenue in UK (2015-2020)
6.7.5 Novartis Key News
6.8 Gilead Sciences Inc.
6.8.1 Gilead Sciences Inc. Corporate Summary
6.8.2 Gilead Sciences Inc. Business Overview
6.8.3 Gilead Sciences Inc. Immuno-Oncology Major Product Offerings
6.8.4 Gilead Sciences Inc. Revenue in UK (2015-2020)
6.8.5 Gilead Sciences Inc. Key News
6.9 Merck KGaA
6.9.1 Merck KGaA Corporate Summary
6.9.2 Merck KGaA Business Overview
6.9.3 Merck KGaA Immuno-Oncology Major Product Offerings
6.9.4 Merck KGaA Revenue in UK (2015-2020)
6.9.5 Merck KGaA Key News
7 KEY MARKET TRENDS & INFLUENCES 2021-2026
7.1 PESTLE Analysis for UK Immuno-Oncology Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Immuno-Oncology Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: UK Immuno-Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 UK IMMUNO-ONCOLOGY OVERALL MARKET SIZE
2.1 UK Immuno-Oncology Market Size: 2020 VS 2026
2.2 UK Immuno-Oncology Revenue, Prospects & Forecasts: 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Immuno-Oncology Players in UK (including Foreign and Local Companies)
3.2 Top UK Immuno-Oncology Companies Ranked by Revenue
3.3 UK Immuno-Oncology Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Immuno-Oncology Companies in UK, by Revenue in 2019
3.5 UK Manufacturers Immuno-Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-Oncology Players in UK
3.6.1 List of UK Tier 1 Immuno-Oncology Companies
3.6.2 List of UK Tier 2 and Tier 3 Immuno-Oncology Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - UK Immuno-Oncology Market Size Markets, 2020 & 2026
4.1.2 Immune Checkpoint Inhibitors
4.1.3 Cytokine-Based Immunotherapy
4.1.4 Cancer Vaccines
4.1.5 CAR-T Cell Therapy
4.1.6 Others
4.2 By Type - UK Immuno-Oncology Revenue & Forecasts
4.2.1 By Type - UK Immuno-Oncology Revenue, 2015-2020
4.2.2 By Type - UK Immuno-Oncology Revenue, 2021-2026
4.2.3 By Type - UK Immuno-Oncology Revenue Market Share, 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - UK Immuno-Oncology Market Size, 2020 & 2026
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - UK Immuno-Oncology Revenue & Forecasts
5.2.1 By Application - UK Immuno-Oncology Revenue, 2015-2020
5.2.2 By Application - UK Immuno-Oncology Revenue, 2021-2026
5.2.3 By Application - UK Immuno-Oncology Revenue Market Share, 2015-2026
6 PLAYERS PROFILES
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporate Summary
6.1.2 Bristol-Myers Squibb Business Overview
6.1.3 Bristol-Myers Squibb Immuno-Oncology Major Product Offerings
6.1.4 Bristol-Myers Squibb Revenue in UK (2015-2020)
6.1.5 Bristol-Myers Squibb Key News
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Corporate Summary
6.2.2 Merck & Co., Inc. Business Overview
6.2.3 Merck & Co., Inc. Immuno-Oncology Major Product Offerings
6.2.4 Merck & Co., Inc. Revenue in UK (2015-2020)
6.2.5 Merck & Co., Inc. Key News
6.3 Roche AG
6.3.1 Roche AG Corporate Summary
6.3.2 Roche AG Business Overview
6.3.3 Roche AG Immuno-Oncology Major Product Offerings
6.3.4 Roche AG Revenue in UK (2015-2020)
6.3.5 Roche AG Key News
6.4 AstraZeneca, Plc
6.4.1 AstraZeneca, Plc Corporate Summary
6.4.2 AstraZeneca, Plc Business Overview
6.4.3 AstraZeneca, Plc Immuno-Oncology Major Product Offerings
6.4.4 AstraZeneca, Plc Revenue in UK (2015-2020)
6.4.5 AstraZeneca, Plc Key News
6.5 Sanofi S.A.
6.5.1 Sanofi S.A. Corporate Summary
6.5.2 Sanofi S.A. Business Overview
6.5.3 Sanofi S.A. Immuno-Oncology Major Product Offerings
6.5.4 Sanofi S.A. Revenue in UK (2015-2020)
6.5.5 Sanofi S.A. Key News
6.6 Dendreon Pharmaceuticals
6.6.1 Dendreon Pharmaceuticals Corporate Summary
6.6.2 Dendreon Pharmaceuticals Business Overview
6.6.3 Dendreon Pharmaceuticals Immuno-Oncology Major Product Offerings
6.6.4 Dendreon Pharmaceuticals Revenue in UK (2015-2020)
6.6.5 Dendreon Pharmaceuticals Key News
6.7 Novartis
6.6.1 Novartis Corporate Summary
6.6.2 Novartis Business Overview
6.6.3 Novartis Immuno-Oncology Major Product Offerings
6.4.4 Novartis Revenue in UK (2015-2020)
6.7.5 Novartis Key News
6.8 Gilead Sciences Inc.
6.8.1 Gilead Sciences Inc. Corporate Summary
6.8.2 Gilead Sciences Inc. Business Overview
6.8.3 Gilead Sciences Inc. Immuno-Oncology Major Product Offerings
6.8.4 Gilead Sciences Inc. Revenue in UK (2015-2020)
6.8.5 Gilead Sciences Inc. Key News
6.9 Merck KGaA
6.9.1 Merck KGaA Corporate Summary
6.9.2 Merck KGaA Business Overview
6.9.3 Merck KGaA Immuno-Oncology Major Product Offerings
6.9.4 Merck KGaA Revenue in UK (2015-2020)
6.9.5 Merck KGaA Key News
7 KEY MARKET TRENDS & INFLUENCES 2021-2026
7.1 PESTLE Analysis for UK Immuno-Oncology Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Immuno-Oncology in UK
Table 2. Top Players in UK, Ranking by Revenue (2019)
Table 3. UK Immuno-Oncology Revenue by Companies, (US$, Mn), 2015-2020
Table 4. UK Immuno-Oncology Revenue Share by Companies, 2015-2020
Table 5. UK Immuno-Oncology Sales by Companies, (K Units), 2015-2020
Table 6. UK Immuno-Oncology Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Immuno-Oncology Price (2015-2020) (US$/Unit)
Table 8. UK Manufacturers Immuno-Oncology Product Type
Table 9. List of UK Tier 1 Immuno-Oncology Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of UK Tier 2 and Tier 3 Immuno-Oncology Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Immuno-Oncology Revenue in UK (US$, Mn), 2015-2020
Table 12. By Type - Immuno-Oncology Revenue in UK (US$, Mn), 2021-2026
Table 13. By Type - Immuno-Oncology Sales in UK (K Units), 2015-2020
Table 14. By Type - Immuno-Oncology Sales in UK (K Units), 2021-2026
Table 15. By Application - Immuno-Oncology Revenue in UK, (US$, Mn), 2015-2020
Table 16. By Application - Immuno-Oncology Revenue in UK, (US$, Mn), 2021-2026
Table 17. By Application - Immuno-Oncology Sales in UK, (K Units), 2015-2020
Table 18. By Application - Immuno-Oncology Sales in UK, (K Units), 2021-2026
Table 19. Bristol-Myers Squibb Corporate Summary
Table 20. Bristol-Myers Squibb Immuno-Oncology Product Offerings
Table 21. Bristol-Myers Squibb Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 22. Merck & Co., Inc. Corporate Summary
Table 23. Merck & Co., Inc. Immuno-Oncology Product Offerings
Table 24. Merck & Co., Inc. Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 25. Roche AG Corporate Summary
Table 26. Roche AG Immuno-Oncology Product Offerings
Table 27. Roche AG Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 28. AstraZeneca, Plc Corporate Summary
Table 29. AstraZeneca, Plc Immuno-Oncology Product Offerings
Table 30. AstraZeneca, Plc Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 31. Sanofi S.A. Corporate Summary
Table 32. Sanofi S.A. Immuno-Oncology Product Offerings
Table 33. Sanofi S.A. Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 34. Dendreon Pharmaceuticals Corporate Summary
Table 35. Dendreon Pharmaceuticals Immuno-Oncology Product Offerings
Table 36. Dendreon Pharmaceuticals Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 37. Novartis Corporate Summary
Table 38. Novartis Immuno-Oncology Product Offerings
Table 39. Novartis Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 40. Gilead Sciences Inc. Corporate Summary
Table 41. Gilead Sciences Inc. Immuno-Oncology Product Offerings
Table 42. Gilead Sciences Inc. Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 43. Merck KGaA Corporate Summary
Table 44. Merck KGaA Immuno-Oncology Product Offerings
Table 45. Merck KGaA Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 1. Key Players of Immuno-Oncology in UK
Table 2. Top Players in UK, Ranking by Revenue (2019)
Table 3. UK Immuno-Oncology Revenue by Companies, (US$, Mn), 2015-2020
Table 4. UK Immuno-Oncology Revenue Share by Companies, 2015-2020
Table 5. UK Immuno-Oncology Sales by Companies, (K Units), 2015-2020
Table 6. UK Immuno-Oncology Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Immuno-Oncology Price (2015-2020) (US$/Unit)
Table 8. UK Manufacturers Immuno-Oncology Product Type
Table 9. List of UK Tier 1 Immuno-Oncology Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of UK Tier 2 and Tier 3 Immuno-Oncology Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Immuno-Oncology Revenue in UK (US$, Mn), 2015-2020
Table 12. By Type - Immuno-Oncology Revenue in UK (US$, Mn), 2021-2026
Table 13. By Type - Immuno-Oncology Sales in UK (K Units), 2015-2020
Table 14. By Type - Immuno-Oncology Sales in UK (K Units), 2021-2026
Table 15. By Application - Immuno-Oncology Revenue in UK, (US$, Mn), 2015-2020
Table 16. By Application - Immuno-Oncology Revenue in UK, (US$, Mn), 2021-2026
Table 17. By Application - Immuno-Oncology Sales in UK, (K Units), 2015-2020
Table 18. By Application - Immuno-Oncology Sales in UK, (K Units), 2021-2026
Table 19. Bristol-Myers Squibb Corporate Summary
Table 20. Bristol-Myers Squibb Immuno-Oncology Product Offerings
Table 21. Bristol-Myers Squibb Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 22. Merck & Co., Inc. Corporate Summary
Table 23. Merck & Co., Inc. Immuno-Oncology Product Offerings
Table 24. Merck & Co., Inc. Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 25. Roche AG Corporate Summary
Table 26. Roche AG Immuno-Oncology Product Offerings
Table 27. Roche AG Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 28. AstraZeneca, Plc Corporate Summary
Table 29. AstraZeneca, Plc Immuno-Oncology Product Offerings
Table 30. AstraZeneca, Plc Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 31. Sanofi S.A. Corporate Summary
Table 32. Sanofi S.A. Immuno-Oncology Product Offerings
Table 33. Sanofi S.A. Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 34. Dendreon Pharmaceuticals Corporate Summary
Table 35. Dendreon Pharmaceuticals Immuno-Oncology Product Offerings
Table 36. Dendreon Pharmaceuticals Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 37. Novartis Corporate Summary
Table 38. Novartis Immuno-Oncology Product Offerings
Table 39. Novartis Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 40. Gilead Sciences Inc. Corporate Summary
Table 41. Gilead Sciences Inc. Immuno-Oncology Product Offerings
Table 42. Gilead Sciences Inc. Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 43. Merck KGaA Corporate Summary
Table 44. Merck KGaA Immuno-Oncology Product Offerings
Table 45. Merck KGaA Immuno-Oncology Revenue (US$, Mn), (2015-2020)
LIST OF FIGURES
Figure 1. Immuno-Oncology Segment by Type
Figure 2. Immuno-Oncology Segment by Application
Figure 3. UK Immuno-Oncology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Immuno-Oncology Market Size in UK, (US$, Mn): 2020 VS 2026
Figure 6. UK Immuno-Oncology Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-Oncology Revenue in 2019
Figure 8. By Type - UK Immuno-Oncology Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - UK Immuno-Oncology Market Share, 2015-2026
Figure 10. By Application - Immuno-Oncology Revenue in UK (US$, Mn), 2020 & 2026
Figure 11. By Application - UK Immuno-Oncology Market Share, 2015-2026
Figure 12. PEST Analysis for UK Immuno-Oncology Market in 2020
Figure 13. Immuno-Oncology Market Opportunities & Trends in UK
Figure 14. Immuno-Oncology Market Drivers in UK
Figure 1. Immuno-Oncology Segment by Type
Figure 2. Immuno-Oncology Segment by Application
Figure 3. UK Immuno-Oncology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Immuno-Oncology Market Size in UK, (US$, Mn): 2020 VS 2026
Figure 6. UK Immuno-Oncology Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-Oncology Revenue in 2019
Figure 8. By Type - UK Immuno-Oncology Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - UK Immuno-Oncology Market Share, 2015-2026
Figure 10. By Application - Immuno-Oncology Revenue in UK (US$, Mn), 2020 & 2026
Figure 11. By Application - UK Immuno-Oncology Market Share, 2015-2026
Figure 12. PEST Analysis for UK Immuno-Oncology Market in 2020
Figure 13. Immuno-Oncology Market Opportunities & Trends in UK
Figure 14. Immuno-Oncology Market Drivers in UK
